US Journal Training, INC., and The Institute for Integral Development  
16th Annual Counseling Skills Conference - 24 CEUs
Friday, September 03, 2010
  Need Assistance? Call 1 800 851 9100  
 

Wednesday, Sept. 3 | Thursday, Sept. 4 | Friday, Sept. 5 | Saturday, Sept. 6


Pre-Conference Workshop Registration
Wednesday, September 3

Printable Conference Schedule

8:00AM - 8:30AM   Pre-Conference Workshop Registration


Meets ETHICS Licensing Requirements-6 hours

PRE-CONFERENCE WORKSHOP REGISTRATION

Therapists struggle with the DSM-IV-TR system and ethical diagnosing of clients. This presentation addresses the Five Axial System with a full review of major diagnoses, informed consent, proper billing, and multicultural and gender bias challenges. Relevant Ethical Principles will be used to highlight ethical and legal issues.


8:30AM - 10:30AM   Pre-Conference Ethics Workshop


Legal and Ethical Considerations when using the DSM-IV-TR: Best Practices


Pamela H. Harmell, Ph.D.
Permanent Lecturer, Pepperdine Graduate School of Education & Psychology, Psychologist, Private Practice, Los Angeles, CA, Chair, CA State Ethics Committee


Introduction to Law and Ethics and DSM System; Substance Related Disorders; Schizophrenia and other Psychotic Disorders.

10:45AM - 11:45AM   Pre-Conference Ethics Workshop


Legal and Ethical Considerations when using the DSM-IV-TR: Best Practices


Pamela H. Harmell, Ph.D.

Childhood Disorders; Accuracy vs. Misrepresentation in Diagnosis; Sexual Disorders; Mood Disorders; Tarasoff Update.


11:45AM - 12:45PM   Pre-Conference Ethics Workshop


Legal and Ethical Considerations when using the DSM-IV-TR: Best Practices


Pamela H. Harmell, Ph.D.

Anxiety Disorders, Eating Disorders, Multicultural Challenges.


2:00PM - 4:00PM   Pre-Conference Ethics Workshop


Legal and Ethical Considerations when using the DSM-IV-TR: Best Practices


Pamela H. Harmell, Ph.D.

Personality Disorders; Breaking Fee of Managed Care; Proper Billing; Multi-Client Situations; Informed Consent.

 

 


Conference Registration

Thursday, September 4

9:30AM - 10:30AM   Conference Registration  

Conference Registration at The Las Vegas Hilton

10:30AM - 12:00PM   Opening Keynote


Affect Regulation and the Repair of the Self: The Right Hemisphere is Dominant in Psychotherapy


Allan Schore, Ph.D.Allan Schore, Ph.D.
Clinical Faculty of the Department of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine and at the UCLA Center for Culture, Brain and Development, Author, Affect Regulation and the Repair of the Self, and Affect Dysregulation and Disorders of the Self.

Dr. Schore will discuss current advances in the neurobiology of attachment, detailing the enduring positive and negative impact of interactively regulated and dysregulated bodily-based affective transactions on the organization of the infant’s early developing right brain, which for the rest of the life span is dominant for the nonconscious processing of emotions, stress regulation, and intersubjectivity. He will then apply the developmental model to psychopathogenesis and the change process of psychotherapy.

1:15PM - 2:45PM   Skill Building Workshops


Regulation Theory and the Paradigm Shift: From Conscious Cognition to Unconscious Affect, Part One


Allan Schore, Ph.D.

In a 2 part presentation, Dr. Schore will describe the critical role of the right brain in implicit facial, gestural, and prosodic communications within the intersubjective field, and in empathy, transference-countertransference, ­mentalization, and affect regulation. This work on regulation theory suggests that more so than insight, interactive regulation within the therapeutic alliance is a central mechanism in the treatment of early forming personality disorders, and that both optimal development and effective psychotherapy promote an expansion of the biological substrate of the human unconscious, the right brain/mind/body system, the dynamic core of the implicit self.


Mood and Attention Disorders: The Neuro-Hormone Connection

Richard Landis, Ph.D.
Trainer, Medical and Clinical Psychologist, Laguna Niguel, CA
Clinical Director, The Intergrative Medical Institute of Orange County


Twenty years ago, the prevailing wisdom saw alteration of the neurotransmitter function at the synaptic sites as the Holy Grail of treating depression. With the advent of a more integrative approach to what it means to be human, we now can see how highly complex and interactive the entire chemical, electrical and mechanical elements of the body work together to keep the system in balance. Changes in any one of these elements can result in varying forms of depression, anxiety and attention difficulties. This course will be a practical look at the Neuro-Hormone and related elements.

3:15PM - 4:45PM   Skill Building Workshops


Regulation Theory and the Paradigm Shift: From Conscious Cognition to Unconscious Affect, Part Two


Allan Schore, Ph.D.

The second of a 2 part presentation, Dr. Schore will describe the critical role of the right brain in implicit facial, gestural, and prosodic communications within the intersubjective field, and in empathy, transference-countertransference, ­mentalization, and affect regulation. This work on regulation theory suggests that more so than insight, interactive regulation within the therapeutic alliance is a central mechanism in the treatment of early forming personality disorders, and that both optimal development and effective psychotherapy promote an expansion of the biological substrate of the human unconscious, the right brain/mind/body system, the dynamic core of the implicit self.


Addiction and the Brain: The Emerging Understanding of Neural Mechanisms of Addiction

Therissa Libby, Ph.D.
Principal, T.A. Libby Group, Adjunct Professor, Towson University, Baltimore, MD

For the past twenty years, the relationship between dopamine-mediated reward and addictive drug use has been explored in depth. Newer research has begun to show the relationship between dopamine reward and a variety of other brain mechanisms, including those underlying learning and memory. This presentation examines this research and places it in the context of understanding addiction as a chronic medical condition.

4:45PM - 6:00PM   Skill Building Workshops


The Development of the Social Brain


Cardwell C. Nuckols, Ph.D.
Conference Chair
One of the Most Influential Clinical Trainers in America. Internationally Recognized Expert in Behavioral Medicine and Addictions Treatment, Longwood, FL. Author, Healing An Angry Heart, Co-Author, Co-Occurring Series: Adolescent Disruptive Behavior Disorders


The trajectory of brain development from childhood through maturity allows for the understanding of the social brain (prefrontal cortical areas) and the survival emphasis of the unconscious mind and ego. This presentation will address the development of unconscious secondary rewards and punishers as seen in addiction and trauma.


The Reality of AOD Recovery as Explained by Neuroscience


Carlton Erickson, Ph.D.
Distinguished Professor of Pharmacology, Associate Dean for Research and Graduate Studies, and Director of the Addiction Science Research and Education Center in the College of Pharmacy at the University of Texas at Austin. Author, The Science of Addiction: From Neurobiology to Treatment

This presentation will examine the scientific evidence for recovery from chemical dependence, contrast it with recovery from drug abuse, and relate both to changes in brain function as a person progresses from abstinence to quality recovery.

 



Friday, September 5

8:15AM - 9:00AM   Conference Registration  

Continental Breakfast

9:00AM - 10:30AM   Keynote


From Discovery to Recovery: Neuroscience, Spirituality and 12-Step Facilitated Recovery—An Evidence Based Training


Cardwell C. Nuckols, Ph.D.Cardwell C Nuckols, Ph.D.
Clinical Faculty of the Department of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine and at the UCLA Center for Culture, Brain and Development, Author, Affect Regulation and the Repair of the Self, and Affect Dysregulation and Disorders of the Self.

In order to understand addictive disorders clinicians working in prevention and intervention need to understand not only the science but the spiritual nature of addiction and recovery. This skills-training integrates
12-step principles of recovery using nonlinear physics, various spiritual teachings (Buddhism, Christianity, etc.), neuroscience and psychology. The goal is always . . . to be of service to others in their personal time of need.

11:00AM - 12:30PM    


Marshak Method: Brain Building and Mind Reconstruction
Yakov Marshak, M.D.

Yakov Marshak, M.D., Ph.D.
Founder/Program Director, Marshak Clinic, Malibu, CA.
Sonia Marshak, M.D., Ph.D.
Founder/Scientific Director, Marshak Clinic, Malibu, CA.

Dr. Yakov Marshak and Dr. Sonia Marshak describe The Marshak Methodtm, a unique, patent pending, methodology for treating chemically dependent adults based on holistic and scientific principles. Developed in Russia with astounding success, The Marshak Method uses genetic polymorphism analysis of genes associated with compulsive/addictive behaviors to identify weak points in catecholamine and serotonin neurotransmission/ Based on the results of genetic testing, treatment is tailored to each individual. The marshak Method uses a comprehensive approach incorporating exercise, nutritional supplements and diet to efficiently restore brain biochemistry and stabilize patient at higher positive mood levels. The Marshak Method includes strong therapeutic component along with the 12-step based philosophy for the foundation of recovery.


1:45 PM - 3:15PM   Skill Building Workshops


What’s Up-the Neuro­biology of Learning and Adolescent Substance Abuse


Merrill A. Norton, Pharm.D., D.Ph., NCAC II, CCS
Clinical Assistant Professor, University of Georgia, College of Pharmacy, Athens, Georgia

This presentation is for professionals who work with adolescents challenged with a psychoactive chemical abuse or dependence issue. The presentation will teach the body of knowledge from recent research relevant to the neurobiology of adolescent learning factors and the impact of psychoactive chemical abuse and dependence on those factors. A review of the latest neurotransmitter and neurohormonal research on the impact of psychoactive chemicals( licit and illicit) on the brain will be the primary focus of this presentation. An overview of the “hijacking of the HPA axis” will also be included in this discussion.


Cannabis and the Brain: An Update


Therissa Libby, Ph.D.

This presentation explores recent findings regarding how cannabis influences brain function and what clinical implications these findings may have. Topics include brain cannabinoid receptors and THC-like substances (endocannabinoids), the effects of cannabis on learning and memory, interactions between cannabinoid and opioid ­systems, and clinical implications.


AOD Recovery in the Future: What Can We Expect?

Carlton Erickson, Ph.D.

This presentation will examine “ideal” (present and future) treatments for drug abuse and chemical dependence and discuss the ways that such treatments relate to recovery management and better health outcomes. The presentation will highlight the brain science of neurotransmitter dysregulation and how this might change during recovery.


3:45PM - 5:15PM   Skill Building Workshops


Prescription Drugs: Abuse and Addiction


Merrill A. Norton, Pharm. D., D.Ph., NCAC II, CCS
Clinical Assistant Professor, University of Georgia, College of Pharmacy, Athens, Georgia

Some people think that prescription drugs are safer and less addictive than street drugs. After all, these are drugs that moms, dads, and even kid brothers and sisters use. To Angie, taking her brother’s ADHD medicine felt like a good way to keep her appetite in check. She’d heard how bad diet pills can be, and she wrongly thought that the ADHD drugs would be safer. This workshop will look at the real drug ­epidemic in America—prescription drug abuse and addiction. The instructor, an addiction pharmacist, will review the latest information on the current trends of prescription abuse and how individuals can help preventing it in their communities.


Is Addiction Really a “Disease?”


Kevin T. McCauley, M.D.
The Institute for Addiction Study

Is addiction a “disease” or a “choice”? This lecture outlines the arguments for and against the conceptualization of addiction as a disease. The most recent neurophysiologic research about addiction is presented, including the five theories currently in use to explain addiction. The connection between this research and the baffling behaviors observed in addicts—behaviors such as of craving, denial and persistent drug use despite negative consequences—is outlined. Finally, the ethical implications of defining addiction as a “disease” are explored, and a new approach to addiction—the “Occupational Model”—is introduced.


Recent Findings on the Genetics of Addiction

Therissa Libby, Ph.D.

In the past decade, investigators have made significant progress in understanding the genetic factors that contribute to addiction, particularly those involved in ­alcohol and opioid addiction. In addition, the emergence of the science of genomics offers the possibility of tailoring medical treatment to one’s individual genetic makeup. This presentation gives participants recent information on how genetics influences the process of addiction.

 

7:00PM - 9:00PM (Optional)   Friday Evening Program

Spend an Evening with Dr. Richard Bandler

 

Visitors interested in Dr. Richard Bandler’s presentation who are not registered
for the conference please call (800)441-5569 and mention CODE 888B.


 

Saturday September 6

8:15AM - 9:00AM   Conference Registration  

Continental Breakfast

9:00AM - 10:30AM   Keynote


The Blending Initiative: Closing the 17 Year Gap Between Research and Treatment
H. Westley Clark, M.D.

H. Westley Clark, M.D., J.D., MPH, CAS, FASAM
Director, Center for Substance Abuse Treatment, SAMHSA, U.S. Dept. of Health and Human Services

According to the Institute of Medicine, it takes approximately 17 years from the time new research results are found and practitioners out in the field actually put that finding to use. However, a joint initiative between SAMHSA’s Center for Substance Abuse Treatment (CSAT) and the National Institute on Drug Abuse (NIDA) is closing that gap. Called “The Blending Initiative” this new approach is ensuring that professionals treating people with substance use disorders have almost immediate access to neuroscientific research results. Dr. H. Westley Clark will describe this unique approach and share some of the teams’ successes.

11:00AM - 12:30PM   Skill Building Workshops


Suboxone . . . How it Works and How it Can Work for your Patients


Carl Rollynn Sullivan, MD
Professor and Director, Addictions Programs WVU School of Medicine, Department of Behavioral Medicine & Psychiatry, Morgantown, WV

We are in an epidemic of prescription opioid dependence in the United States. This workshop will present a review of opioid usage in the U.S. A discussion will occur about new, outpatient medication treatment for managing these patients. There will be a special emphasis on the pharmacology of buprenorphine and why it is a unique opioid. There will also be a discussion on how to manage a successful Suboxone clinic so that your patients derive maximal benefit from this medicine and increase their chances for recovery.


Recovery-Oriented Systems of Care

H.Westley Clark, M.D., J.D., M.P.H., CAS, FASAM

Recovery from alcohol and drug addiction is a process of change. The most effective treatment is a holistic approach that takes advantage of the services and support offered by a wide variety of resources. Each individual’s situation is different and, therefore, responds to different services and support systems. The Recovery-Oriented Systems of Care (ROSC) approach places the responsibility for recovery on the client, while the various supports work in harmony toward the client’s recovery.


Beyond the “Disease Model” of Addiction

Kevin T. McCauley, M.D.

If addiction is a “disease,” what does that mean? This lecture goes beyond the Disease Model argument to ask the most exciting questions about addiction: Where does spirituality fit in with all this brain science? What’s to keep the addict from using “I have a disease” to avoid responsibility? Does punishment and coercion really work to change addictive behavior, and even if it does—should we do it? The exciting field of Neuroeconomics—the science of how people make choices-is introduced.


1:45PM - 3:15PM   Skill Building Workshops


The Development of the Spiritual Brain


Cardwell C. Nuckols, Ph.D.

This presentation will address the spiritual evolution attributed more to the right hemisphere. Also emphasized will be the transitional ego state and the development of the physiology of the spiritually-based right hemisphere as seen in the serenity of recovery.


Not Just Blowing Smoke. . . . How to Treat Nicotine Dependence

Carl Rollynn Sullivan, M.D.

This workshop will focus on nicotine addiction. A discussion will occur about prevalence of nicotine dependence, how nicotine acts on the brain and treatment options available to the clinician and patients wanting to stop smoking. We will talk about nicotine addiction as a chronic brain disease. The primary focus will be on cigarette smoking.


3:30PM - 5:00PM   Skill Building Workshops


The First Year of Recovery


Kevin T. McCauley, M.D.

There is no need to be pessimistic about the chances for recovery from addiction. There are certain groups of addicts that have higher than 80% chance of achieving their first year of sobriety after their first time through treatment. This lecture talks about these groups and how all patients can have similar success rates. The concept of Post-Acute Withdrawal symptomology is introduced as well as the Occupational Model of recovery. Challenges of depression, anxiety and insomnia in early recovery are presented along with non-pharmacologic treatments. Emphasis is on building skills to manage the symptoms of Post-Acute Withdrawal Syndrome and reduce relapse risk after discharge from treatment.


Chronic Pain and Addiction

Carl Rollynn Sullivan, M.D.

This session will focus on the interface between chronic, non-malignant pain and drug addiction. Common problems will be discussed especially as is related to long-tern opioid usage. Hyperalgesia and allodynia in the context of prolonged opioid usage in chronic pain will also be discussed. Non-addicting drug alternatives will be presented and a discussion will occur on identifying the addict in a population of pain patients.

 


Register Early, Space is Limited Call 800 441 5569


Register | Conference Details | Faculty | Hotel & Travel | Approved By

 

 

U.S. Journal Training, Inc.
3201 SW 15th St. Deerfield Beach, FL 33442
Phone: 1-800-851-9100/954-360-0909
Terms under which this service is provided to you.
Read our privacy guidelines.
Copyright 2010. Please review our Refund Policy.